These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 19190825)

  • 1. Expression analysis and study of KLK4 in benign and malignant breast tumours.
    Papachristopoulou G; Avgeris M; Scorilas A
    Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
    Avgeris M; Stravodimos K; Scorilas A
    Prostate; 2011 Dec; 71(16):1780-9. PubMed ID: 21520157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues.
    Papachristopoulou G; Avgeris M; Charlaftis A; Scorilas A
    Thromb Haemost; 2011 Jan; 105(1):131-7. PubMed ID: 21057706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
    Kontos CK; Papadopoulos IN; Scorilas A
    Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
    Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
    Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific increase of human kallikrein 4 mRNA and protein levels in breast cancer stromal cells.
    Mangé A; Desmetz C; Berthes ML; Maudelonde T; Solassol J
    Biochem Biophys Res Commun; 2008 Oct; 375(1):107-12. PubMed ID: 18687310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
    Obiezu CV; Scorilas A; Katsaros D; Massobrio M; Yousef GM; Fracchioli S; Rigault de la Longrais IA; Arisio R; Diamandis EP
    Clin Cancer Res; 2001 Aug; 7(8):2380-6. PubMed ID: 11489816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma.
    Cejas P; García-Cabezas MA; Casado E; Belda-Iniesta C; De Castro J; Fresno JA; Sereno M; Barriuso J; Espinosa E; Zamora P; Feliu J; Redondo A; Hardisson DA; Renart J; González-Barón M
    Free Radic Res; 2007 Jun; 41(6):681-7. PubMed ID: 17516241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC; Wang F; Elliott RL; Head JF
    Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
    Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
    Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
    Avgeris M; Koutalellis G; Fragoulis EG; Scorilas A
    Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
    Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of BRCA2 gene in sporadic breast tumours.
    Bièche I; Noguès C; Lidereau R
    Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies.
    Bryś M; Wójcik M; Romanowicz-Makowska H; Krajewska WM
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):85-90. PubMed ID: 11862478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
    Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
    Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
    Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.